Literature DB >> 21920498

Oral ecosystem alterations in celiac children: a follow-up study.

Silvia Mina1, Carolina Riga, Ana Isabel Azcurra, Mabel Brunotto.   

Abstract

OBJECTIVE: The aims of this work were (1) to assess the oral health status of children with celiac disease (CD) with or without compliance with a gluten-free diet and in non-celiac children in a follow-up study and (2) to identify oral ecosystem changes that could be used as non-invasive monitoring methods for CD patients. STUDY
DESIGN: An 18-month follow-up study in children of both genders, who were 4-12 years old during the study period, was performed. Decayed-missing-filled in temporary (dmft) and permanent teeth (DMFT), enamel alterations, oral hygiene, and gingival index were measured. Oral smears were collected by brushing. Flow rate, calcium, phosphate, pH, buffer capacity, fluoride, and Ca/P ratio were measured in saliva. Salivary protein profiles were performed.
RESULTS: Most CD patients (80%) presented typical symptoms between 12 and 24 months old. Children with CD had a significantly low frequency of enamel alterations (30%) (p=0.0001). A high percentage of patients (63.15%) reported having had aphthous ulcers at several times. The celiac group showed significantly more polymorphonuclear neutrophils (PMNs) in smears (20% PMNs per area, p=0.0459) than the control group (0% PMNs per area) at baseline. In CD children, 90% of the samples that showed PMNs at baseline did not present them after 18 months. However, 10% of the smears of CD patients presented PMNs at the end of this study. Compliance with the gluten-free diet was controlled to detect the maintenance or worsening of signs and symptoms during the medical controls.
CONCLUSIONS: The main differences amongst CD children who did or did not comply with a gluten-free diet and control children are the presence of PMNs in oral mucosa and protein salivary patterns; these findings could be considered as markers for CD, in conjunction with other signs and symptoms.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920498     DOI: 10.1016/j.archoralbio.2011.08.017

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  6 in total

1.  Salivary microbiota and metabolome associated with celiac disease.

Authors:  Ruggiero Francavilla; Danilo Ercolini; Maria Piccolo; Lucia Vannini; Sonya Siragusa; Francesca De Filippis; Ilaria De Pasquale; Raffaella Di Cagno; Michele Di Toma; Giorgia Gozzi; Diana I Serrazanetti; Maria De Angelis; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

2.  The anti-transglutaminase auto-antibodies in children's saliva with a suspect coeliac disease: clinical study.

Authors:  R Condò; M Costacurta; R Docimo
Journal:  Oral Implantol (Rome)       Date:  2013-10-15

3.  Oral Manifestations in Pediatric Patients with Coeliac Disease - A Review Article.

Authors:  Viviana Marisa Pereira Macho; Ana Sofia Coelho; Diana Maria Veloso E Silva; David José Casimiro de Andrade
Journal:  Open Dent J       Date:  2017-10-24

Review 4.  Oral Health Impact Profile in Celiac Patients: Analysis of Recent Findings in a Literature Review.

Authors:  Gabriele Cervino; Luca Fiorillo; Luigi Laino; Alan Scott Herford; Floriana Lauritano; Giuseppe Lo Giudice; Fausto Famà; Rossella Santoro; Giuseppe Troiano; Gaetano Iannello; Marco Cicciù
Journal:  Gastroenterol Res Pract       Date:  2018-10-24       Impact factor: 2.260

Review 5.  Extra-Intestinal Manifestation of Celiac Disease in Children.

Authors:  Hilary Jericho; Stefano Guandalini
Journal:  Nutrients       Date:  2018-06-12       Impact factor: 5.717

6.  The difference in symmetry of the enamel defects in celiac disease versus non-celiac pediatric population.

Authors:  Viviana Marisa Pereira Macho; Maria Conceição Antas de Barros Menéres Manso; Diana Maria Veloso E Silva; David José Casimiro de Andrade
Journal:  J Dent Sci       Date:  2020-03-28       Impact factor: 2.080

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.